Cocrystal Pharma Inc
NASDAQ:COCP

Watchlist Manager
Cocrystal Pharma Inc Logo
Cocrystal Pharma Inc
NASDAQ:COCP
Watchlist
Price: 1.57 USD 5.37% Market Closed
Market Cap: 16m USD

Intrinsic Value

COCP's intrinsic value estimate is unreliable because it is based only on its DCF value and doesn't use a relative valuation using multiples.

The intrinsic value of one COCP stock under the Base Case scenario is 0.69 USD. Compared to the current market price of 1.57 USD, Cocrystal Pharma Inc is Overvalued by 56%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

COCP Intrinsic Value
0.69 USD
Overvaluation 56%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Cocrystal Pharma Inc

Valuation History Unavailable

Historical valuation for COCP cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare COCP to

Fundamental Analysis

Company Overview
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about COCP?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Cocrystal Pharma Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Cocrystal Pharma Inc

Current Assets 8.8m
Cash & Short-Term Investments 6.9m
Receivables 1.4m
Other Current Assets 460k
Non-Current Assets 1.8m
Long-Term Investments 86k
PP&E 1.7m
Efficiency

Free Cash Flow Analysis
Cocrystal Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Cocrystal Pharma Inc

Revenue
0 USD
Operating Expenses
-16.1m USD
Operating Income
-16.1m USD
Other Expenses
212k USD
Net Income
-15.8m USD
Fundamental Scores

COCP Profitability Score
Profitability Due Diligence

Cocrystal Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

23/100
Profitability
Score

Cocrystal Pharma Inc's profitability score is 23/100. The higher the profitability score, the more profitable the company is.

COCP Solvency Score
Solvency Due Diligence

Cocrystal Pharma Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Low D/E
Long-Term Solvency
Low Altman Z-Score
59/100
Solvency
Score

Cocrystal Pharma Inc's solvency score is 59/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

COCP Price Targets Summary
Cocrystal Pharma Inc

Wall Street analysts forecast COCP stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for COCP is 8.5 USD with a low forecast of 7.07 USD and a high forecast of 10.5 USD.

Lowest
Price Target
7.07 USD
350% Upside
Average
Price Target
8.5 USD
441% Upside
Highest
Price Target
10.5 USD
569% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Cocrystal Pharma Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for COCP is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

COCP Insider Trading
Buy and sell transactions by insiders

COCP News

What is the Intrinsic Value of one COCP stock?

The intrinsic value of one COCP stock under the Base Case scenario is 0.69 USD.

Is COCP stock undervalued or overvalued?

Compared to the current market price of 1.57 USD, Cocrystal Pharma Inc is Overvalued by 56%.

Back to Top